Atlas Trials

Validation of the Oncoliq Test for the Early Detection of Breast Cancer.

Clinical trial NCT07331506 · RECRUITING

Trial details

NCT number
NCT07331506
Sponsor
Oncoliq US Inc
Status
RECRUITING
Study type
OBSERVATIONAL
Breast Cancer DetectionBreast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Cancer FemaleBreast Cancer - Ductal Carcinoma in Situ (DCIS)Breast Cancer - Infiltrating Ductal CarcinomaBreast Cancer With Low to Intermediate HER2 ExpressionBreast Cancer (Early Breast Cancer)Breast Cancer - Female
Start date
2025-10-17
Primary completion
2026-02-28
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.